nodes	percent_of_prediction	percent_of_DWPC	metapath
Aminolevulinic acid—ALAD—urine—prostate cancer	0.0774	0.343	CbGeAlD
Aminolevulinic acid—ALAD—prostate gland—prostate cancer	0.0278	0.123	CbGeAlD
Aminolevulinic acid—ALAD—renal system—prostate cancer	0.0189	0.0839	CbGeAlD
Aminolevulinic acid—ALAD—urethra—prostate cancer	0.0186	0.0825	CbGeAlD
Aminolevulinic acid—ALAD—bone marrow—prostate cancer	0.0143	0.0635	CbGeAlD
Aminolevulinic acid—ALAD—testis—prostate cancer	0.0122	0.0543	CbGeAlD
Aminolevulinic acid—SLC15A1—epithelium—prostate cancer	0.00896	0.0397	CbGeAlD
Aminolevulinic acid—ALAD—lymph node—prostate cancer	0.00887	0.0393	CbGeAlD
Aminolevulinic acid—SLC15A1—renal system—prostate cancer	0.00831	0.0368	CbGeAlD
Aminolevulinic acid—Azelaic Acid—SRD5A2—prostate cancer	0.00816	0.364	CrCbGaD
Aminolevulinic acid—SLC15A2—prostate gland—prostate cancer	0.00762	0.0338	CbGeAlD
Aminolevulinic acid—SLC15A2—seminal vesicle—prostate cancer	0.00645	0.0286	CbGeAlD
Aminolevulinic acid—Aminocaproic Acid—AOX1—prostate cancer	0.00602	0.268	CrCbGaD
Aminolevulinic acid—SLC15A2—renal system—prostate cancer	0.00519	0.023	CbGeAlD
Aminolevulinic acid—SLC15A2—urethra—prostate cancer	0.0051	0.0226	CbGeAlD
Aminolevulinic acid—Glycine—GNMT—prostate cancer	0.00432	0.192	CrCbGaD
Aminolevulinic acid—L-Glutamine—QARS—prostate cancer	0.00394	0.176	CrCbGaD
Aminolevulinic acid—SLC15A2—Amino acid and oligopeptide SLC transporters—SLC7A1—prostate cancer	0.00352	0.0405	CbGpPWpGaD
Aminolevulinic acid—SLC15A2—testis—prostate cancer	0.00336	0.0149	CbGeAlD
Aminolevulinic acid—SLC15A1—Amino acid and oligopeptide SLC transporters—SLC7A1—prostate cancer	0.00327	0.0376	CbGpPWpGaD
Aminolevulinic acid—SLC15A2—lymph node—prostate cancer	0.00243	0.0108	CbGeAlD
Aminolevulinic acid—SLC15A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC7A1—prostate cancer	0.00207	0.0238	CbGpPWpGaD
Aminolevulinic acid—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC7A1—prostate cancer	0.00192	0.0221	CbGpPWpGaD
Aminolevulinic acid—SLC15A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC12A2—prostate cancer	0.0013	0.015	CbGpPWpGaD
Aminolevulinic acid—SLC15A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC26A4—prostate cancer	0.0013	0.015	CbGpPWpGaD
Aminolevulinic acid—ALAD—Metabolism—HAO1—prostate cancer	0.00128	0.0147	CbGpPWpGaD
Aminolevulinic acid—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC12A2—prostate cancer	0.00121	0.0139	CbGpPWpGaD
Aminolevulinic acid—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC26A4—prostate cancer	0.00121	0.0139	CbGpPWpGaD
Aminolevulinic acid—SLC15A2—Amino acid and oligopeptide SLC transporters—SLC5A5—prostate cancer	0.00107	0.0123	CbGpPWpGaD
Aminolevulinic acid—ALAD—Metabolism—PSAT1—prostate cancer	0.00104	0.012	CbGpPWpGaD
Aminolevulinic acid—ALAD—Metabolism—CBR1—prostate cancer	0.00104	0.012	CbGpPWpGaD
Aminolevulinic acid—ALAD—Metabolism—GRHL1—prostate cancer	0.00104	0.012	CbGpPWpGaD
Aminolevulinic acid—ALAD—Metabolism—CSAD—prostate cancer	0.00104	0.012	CbGpPWpGaD
Aminolevulinic acid—ALAD—Metabolism—ADI1—prostate cancer	0.00104	0.012	CbGpPWpGaD
Aminolevulinic acid—ALAD—Metabolism—TST—prostate cancer	0.00104	0.012	CbGpPWpGaD
Aminolevulinic acid—SLC15A1—Amino acid and oligopeptide SLC transporters—SLC5A5—prostate cancer	0.000989	0.0114	CbGpPWpGaD
Aminolevulinic acid—ALAD—Metabolism—UGT2B15—prostate cancer	0.00097	0.0112	CbGpPWpGaD
Aminolevulinic acid—ALAD—Metabolism—UGT2B17—prostate cancer	0.00097	0.0112	CbGpPWpGaD
Aminolevulinic acid—ALAD—Metabolism—GRHPR—prostate cancer	0.00097	0.0112	CbGpPWpGaD
Aminolevulinic acid—ALAD—Metabolism—CKMT2—prostate cancer	0.00097	0.0112	CbGpPWpGaD
Aminolevulinic acid—SLC15A2—SLC-mediated transmembrane transport—SLC7A1—prostate cancer	0.000926	0.0106	CbGpPWpGaD
Aminolevulinic acid—ALAD—Metabolism—NAGLU—prostate cancer	0.000912	0.0105	CbGpPWpGaD
Aminolevulinic acid—ALAD—Metabolism—PGAM2—prostate cancer	0.000912	0.0105	CbGpPWpGaD
Aminolevulinic acid—ALAD—Metabolism—SULT2B1—prostate cancer	0.000912	0.0105	CbGpPWpGaD
Aminolevulinic acid—ALAD—Metabolism—MBTPS1—prostate cancer	0.000912	0.0105	CbGpPWpGaD
Aminolevulinic acid—ALAD—Metabolism—AOX1—prostate cancer	0.000912	0.0105	CbGpPWpGaD
Aminolevulinic acid—ALAD—Metabolism—GSTM3—prostate cancer	0.000912	0.0105	CbGpPWpGaD
Aminolevulinic acid—ALAD—Metabolism—RFK—prostate cancer	0.000912	0.0105	CbGpPWpGaD
Aminolevulinic acid—ALAD—Metabolism—CYP3A43—prostate cancer	0.000864	0.00994	CbGpPWpGaD
Aminolevulinic acid—ALAD—Metabolism—AMACR—prostate cancer	0.000864	0.00994	CbGpPWpGaD
Aminolevulinic acid—ALAD—Metabolism—SRD5A2—prostate cancer	0.000864	0.00994	CbGpPWpGaD
Aminolevulinic acid—ALAD—Metabolism—NAT1—prostate cancer	0.000864	0.00994	CbGpPWpGaD
Aminolevulinic acid—ALAD—Metabolism—DEGS1—prostate cancer	0.000864	0.00994	CbGpPWpGaD
Aminolevulinic acid—SLC15A1—SLC-mediated transmembrane transport—SLC7A1—prostate cancer	0.000859	0.00988	CbGpPWpGaD
Aminolevulinic acid—ALAD—Metabolism—HSD17B1—prostate cancer	0.000824	0.00948	CbGpPWpGaD
Aminolevulinic acid—ALAD—Metabolism—B4GALT4—prostate cancer	0.000735	0.00845	CbGpPWpGaD
Aminolevulinic acid—ALAD—Metabolism—HPGD—prostate cancer	0.000735	0.00845	CbGpPWpGaD
Aminolevulinic acid—SLC15A2—SLC-mediated transmembrane transport—SLC39A1—prostate cancer	0.000732	0.00842	CbGpPWpGaD
Aminolevulinic acid—ALAD—Metabolism—TNFRSF21—prostate cancer	0.000691	0.00795	CbGpPWpGaD
Aminolevulinic acid—SLC15A1—SLC-mediated transmembrane transport—SLC39A1—prostate cancer	0.000679	0.00781	CbGpPWpGaD
Aminolevulinic acid—ALAD—Metabolism—CYP7B1—prostate cancer	0.000672	0.00773	CbGpPWpGaD
Aminolevulinic acid—ALAD—Metabolism—MTAP—prostate cancer	0.000672	0.00773	CbGpPWpGaD
Aminolevulinic acid—ALAD—Metabolism—SRD5A1—prostate cancer	0.000655	0.00753	CbGpPWpGaD
Aminolevulinic acid—ALAD—Metabolism—SULT1E1—prostate cancer	0.000655	0.00753	CbGpPWpGaD
Aminolevulinic acid—SLC15A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC5A5—prostate cancer	0.000628	0.00722	CbGpPWpGaD
Aminolevulinic acid—ALAD—Metabolism—ACSL4—prostate cancer	0.000625	0.00719	CbGpPWpGaD
Aminolevulinic acid—ALAD—Metabolism—HSD17B3—prostate cancer	0.000625	0.00719	CbGpPWpGaD
Aminolevulinic acid—ALAD—Metabolism—ARG2—prostate cancer	0.000599	0.00689	CbGpPWpGaD
Aminolevulinic acid—ALAD—Metabolism—UMPS—prostate cancer	0.000599	0.00689	CbGpPWpGaD
Aminolevulinic acid—ALAD—Metabolism—PHGDH—prostate cancer	0.000599	0.00689	CbGpPWpGaD
Aminolevulinic acid—ALAD—Metabolism—LDHB—prostate cancer	0.000587	0.00676	CbGpPWpGaD
Aminolevulinic acid—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC5A5—prostate cancer	0.000582	0.0067	CbGpPWpGaD
Aminolevulinic acid—SLC15A2—SLC-mediated transmembrane transport—SLC12A2—prostate cancer	0.000581	0.00669	CbGpPWpGaD
Aminolevulinic acid—SLC15A2—SLC-mediated transmembrane transport—SLC26A4—prostate cancer	0.000581	0.00669	CbGpPWpGaD
Aminolevulinic acid—ALAD—Metabolism—CYP3A5—prostate cancer	0.000577	0.00663	CbGpPWpGaD
Aminolevulinic acid—ALAD—Metabolism—PDHA1—prostate cancer	0.000557	0.0064	CbGpPWpGaD
Aminolevulinic acid—ALAD—Metabolism—GSTA3—prostate cancer	0.000557	0.0064	CbGpPWpGaD
Aminolevulinic acid—ALAD—Metabolism—UCP3—prostate cancer	0.000557	0.0064	CbGpPWpGaD
Aminolevulinic acid—ALAD—Metabolism—TCN2—prostate cancer	0.000557	0.0064	CbGpPWpGaD
Aminolevulinic acid—SLC15A1—SLC-mediated transmembrane transport—SLC26A4—prostate cancer	0.00054	0.00621	CbGpPWpGaD
Aminolevulinic acid—SLC15A1—SLC-mediated transmembrane transport—SLC12A2—prostate cancer	0.00054	0.00621	CbGpPWpGaD
Aminolevulinic acid—ALAD—Metabolism—HSD3B1—prostate cancer	0.000531	0.00611	CbGpPWpGaD
Aminolevulinic acid—ALAD—Metabolism—SLC22A3—prostate cancer	0.000531	0.00611	CbGpPWpGaD
Aminolevulinic acid—ALAD—Metabolism—TBXAS1—prostate cancer	0.000509	0.00586	CbGpPWpGaD
Aminolevulinic acid—ALAD—Metabolism—GSTA4—prostate cancer	0.000509	0.00586	CbGpPWpGaD
Aminolevulinic acid—Infestation—Docetaxel—prostate cancer	0.000509	0.000766	CcSEcCtD
Aminolevulinic acid—Photosensitivity—Epirubicin—prostate cancer	0.000508	0.000763	CcSEcCtD
Aminolevulinic acid—Urticaria—Goserelin—prostate cancer	0.000505	0.00076	CcSEcCtD
Aminolevulinic acid—Photosensitivity reaction—Capecitabine—prostate cancer	0.000505	0.000759	CcSEcCtD
Aminolevulinic acid—Oedema—Estradiol—prostate cancer	0.000504	0.000758	CcSEcCtD
Aminolevulinic acid—Body temperature increased—Goserelin—prostate cancer	0.000503	0.000756	CcSEcCtD
Aminolevulinic acid—Alanine aminotransferase increased—Prednisone—prostate cancer	0.000503	0.000756	CcSEcCtD
Aminolevulinic acid—Infection—Estradiol—prostate cancer	0.000501	0.000753	CcSEcCtD
Aminolevulinic acid—Urticaria—Conjugated Estrogens—prostate cancer	0.000501	0.000753	CcSEcCtD
Aminolevulinic acid—Angiopathy—Etoposide—prostate cancer	0.000499	0.00075	CcSEcCtD
Aminolevulinic acid—Convulsion—Mitoxantrone—prostate cancer	0.000499	0.00075	CcSEcCtD
Aminolevulinic acid—Body temperature increased—Conjugated Estrogens—prostate cancer	0.000498	0.000749	CcSEcCtD
Aminolevulinic acid—ALAD—Metabolism—GSTA2—prostate cancer	0.000496	0.00571	CbGpPWpGaD
Aminolevulinic acid—Nervous system disorder—Estradiol—prostate cancer	0.000495	0.000743	CcSEcCtD
Aminolevulinic acid—Chills—Etoposide—prostate cancer	0.000494	0.000742	CcSEcCtD
Aminolevulinic acid—Infestation NOS—Capecitabine—prostate cancer	0.000493	0.000741	CcSEcCtD
Aminolevulinic acid—Infestation—Capecitabine—prostate cancer	0.000493	0.000741	CcSEcCtD
Aminolevulinic acid—Vomiting—Ethinyl Estradiol—prostate cancer	0.000491	0.000739	CcSEcCtD
Aminolevulinic acid—ALAD—Metabolism—ABCG5—prostate cancer	0.00049	0.00564	CbGpPWpGaD
Aminolevulinic acid—ALAD—Metabolism—SULT1A1—prostate cancer	0.00049	0.00564	CbGpPWpGaD
Aminolevulinic acid—Skin disorder—Estradiol—prostate cancer	0.00049	0.000736	CcSEcCtD
Aminolevulinic acid—Rash—Ethinyl Estradiol—prostate cancer	0.000487	0.000733	CcSEcCtD
Aminolevulinic acid—Dermatitis—Ethinyl Estradiol—prostate cancer	0.000487	0.000732	CcSEcCtD
Aminolevulinic acid—Discomfort—Mitoxantrone—prostate cancer	0.000484	0.000728	CcSEcCtD
Aminolevulinic acid—Headache—Ethinyl Estradiol—prostate cancer	0.000484	0.000728	CcSEcCtD
Aminolevulinic acid—Hepatobiliary disease—Docetaxel—prostate cancer	0.000482	0.000724	CcSEcCtD
Aminolevulinic acid—ALAD—Metabolism—GSTA1—prostate cancer	0.000479	0.00551	CbGpPWpGaD
Aminolevulinic acid—ALAD—Metabolism—NAT2—prostate cancer	0.000474	0.00545	CbGpPWpGaD
Aminolevulinic acid—ALAD—Metabolism—GSTO1—prostate cancer	0.000474	0.00545	CbGpPWpGaD
Aminolevulinic acid—ALAD—Metabolism—HSD3B2—prostate cancer	0.000474	0.00545	CbGpPWpGaD
Aminolevulinic acid—SLC15A2—SLC-mediated transmembrane transport—SLC22A3—prostate cancer	0.000472	0.00542	CbGpPWpGaD
Aminolevulinic acid—SLC15A2—Transmembrane transport of small molecules—SLC7A1—prostate cancer	0.00047	0.00541	CbGpPWpGaD
Aminolevulinic acid—Oedema—Mitoxantrone—prostate cancer	0.00047	0.000706	CcSEcCtD
Aminolevulinic acid—Photosensitivity—Doxorubicin—prostate cancer	0.00047	0.000706	CcSEcCtD
Aminolevulinic acid—Infection—Mitoxantrone—prostate cancer	0.000467	0.000702	CcSEcCtD
Aminolevulinic acid—Hepatobiliary disease—Capecitabine—prostate cancer	0.000466	0.000701	CcSEcCtD
Aminolevulinic acid—Thrombocytopenia—Mitoxantrone—prostate cancer	0.00046	0.000692	CcSEcCtD
Aminolevulinic acid—Haemoglobin—Docetaxel—prostate cancer	0.00046	0.000691	CcSEcCtD
Aminolevulinic acid—Nausea—Ethinyl Estradiol—prostate cancer	0.000459	0.00069	CcSEcCtD
Aminolevulinic acid—Haemorrhage—Docetaxel—prostate cancer	0.000457	0.000687	CcSEcCtD
Aminolevulinic acid—Skin disorder—Mitoxantrone—prostate cancer	0.000456	0.000686	CcSEcCtD
Aminolevulinic acid—Hypoaesthesia—Docetaxel—prostate cancer	0.000455	0.000684	CcSEcCtD
Aminolevulinic acid—ALAD—Metabolism—PLCB2—prostate cancer	0.000454	0.00522	CbGpPWpGaD
Aminolevulinic acid—ALAD—Metabolism—CYP2C18—prostate cancer	0.000454	0.00522	CbGpPWpGaD
Aminolevulinic acid—ALAD—Metabolism—LRP2—prostate cancer	0.000454	0.00522	CbGpPWpGaD
Aminolevulinic acid—Paraesthesia—Estradiol—prostate cancer	0.000453	0.000681	CcSEcCtD
Aminolevulinic acid—Pruritus—Goserelin—prostate cancer	0.00045	0.000677	CcSEcCtD
Aminolevulinic acid—Pruritus—Conjugated Estrogens—prostate cancer	0.000446	0.00067	CcSEcCtD
Aminolevulinic acid—ALAD—Metabolism—P4HB—prostate cancer	0.000445	0.00512	CbGpPWpGaD
Aminolevulinic acid—Haemoglobin—Capecitabine—prostate cancer	0.000445	0.000669	CcSEcCtD
Aminolevulinic acid—Haemorrhage—Capecitabine—prostate cancer	0.000443	0.000665	CcSEcCtD
Aminolevulinic acid—Anaemia—Etoposide—prostate cancer	0.000443	0.000665	CcSEcCtD
Aminolevulinic acid—Hypoaesthesia—Capecitabine—prostate cancer	0.00044	0.000662	CcSEcCtD
Aminolevulinic acid—Hypotension—Mitoxantrone—prostate cancer	0.000439	0.00066	CcSEcCtD
Aminolevulinic acid—SLC15A1—SLC-mediated transmembrane transport—SLC22A3—prostate cancer	0.000438	0.00503	CbGpPWpGaD
Aminolevulinic acid—SLC15A1—Transmembrane transport of small molecules—SLC7A1—prostate cancer	0.000437	0.00502	CbGpPWpGaD
Aminolevulinic acid—Gastrointestinal disorder—Estradiol—prostate cancer	0.000435	0.000655	CcSEcCtD
Aminolevulinic acid—Diarrhoea—Goserelin—prostate cancer	0.000435	0.000654	CcSEcCtD
Aminolevulinic acid—ALAD—Metabolism—SLC22A1—prostate cancer	0.000433	0.00498	CbGpPWpGaD
Aminolevulinic acid—Pain—Estradiol—prostate cancer	0.000431	0.000648	CcSEcCtD
Aminolevulinic acid—Diarrhoea—Conjugated Estrogens—prostate cancer	0.000431	0.000648	CcSEcCtD
Aminolevulinic acid—Eye disorder—Docetaxel—prostate cancer	0.000427	0.000642	CcSEcCtD
Aminolevulinic acid—Cardiac disorder—Docetaxel—prostate cancer	0.000424	0.000638	CcSEcCtD
Aminolevulinic acid—ALAD—Metabolism—SULT2A1—prostate cancer	0.000422	0.00485	CbGpPWpGaD
Aminolevulinic acid—Paraesthesia—Mitoxantrone—prostate cancer	0.000422	0.000634	CcSEcCtD
Aminolevulinic acid—ALAD—Metabolism—MED12—prostate cancer	0.000415	0.00478	CbGpPWpGaD
Aminolevulinic acid—Convulsion—Etoposide—prostate cancer	0.000415	0.000624	CcSEcCtD
Aminolevulinic acid—Angiopathy—Docetaxel—prostate cancer	0.000415	0.000624	CcSEcCtD
Aminolevulinic acid—Eye disorder—Capecitabine—prostate cancer	0.000414	0.000622	CcSEcCtD
Aminolevulinic acid—ALAD—Metabolism—GNG5—prostate cancer	0.000412	0.00474	CbGpPWpGaD
Aminolevulinic acid—Cardiac disorder—Capecitabine—prostate cancer	0.000411	0.000618	CcSEcCtD
Aminolevulinic acid—Chills—Docetaxel—prostate cancer	0.00041	0.000617	CcSEcCtD
Aminolevulinic acid—Dry skin—Epirubicin—prostate cancer	0.000409	0.000614	CcSEcCtD
Aminolevulinic acid—Unspecified disorder of skin and subcutaneous tissue—Etoposide—prostate cancer	0.000405	0.000609	CcSEcCtD
Aminolevulinic acid—Vomiting—Goserelin—prostate cancer	0.000404	0.000608	CcSEcCtD
Aminolevulinic acid—Discomfort—Etoposide—prostate cancer	0.000403	0.000606	CcSEcCtD
Aminolevulinic acid—Pain—Mitoxantrone—prostate cancer	0.000402	0.000604	CcSEcCtD
Aminolevulinic acid—Angiopathy—Capecitabine—prostate cancer	0.000402	0.000604	CcSEcCtD
Aminolevulinic acid—Aspartate aminotransferase increased—Epirubicin—prostate cancer	0.000401	0.000603	CcSEcCtD
Aminolevulinic acid—Rash—Goserelin—prostate cancer	0.000401	0.000603	CcSEcCtD
Aminolevulinic acid—Dermatitis—Goserelin—prostate cancer	0.000401	0.000602	CcSEcCtD
Aminolevulinic acid—Vomiting—Conjugated Estrogens—prostate cancer	0.000401	0.000602	CcSEcCtD
Aminolevulinic acid—Urticaria—Estradiol—prostate cancer	0.000401	0.000602	CcSEcCtD
Aminolevulinic acid—Mental disorder—Docetaxel—prostate cancer	0.000401	0.000602	CcSEcCtD
Aminolevulinic acid—Body temperature increased—Estradiol—prostate cancer	0.000399	0.000599	CcSEcCtD
Aminolevulinic acid—Headache—Goserelin—prostate cancer	0.000399	0.000599	CcSEcCtD
Aminolevulinic acid—Erythema—Docetaxel—prostate cancer	0.000398	0.000598	CcSEcCtD
Aminolevulinic acid—Rash—Conjugated Estrogens—prostate cancer	0.000397	0.000597	CcSEcCtD
Aminolevulinic acid—Chills—Capecitabine—prostate cancer	0.000397	0.000597	CcSEcCtD
Aminolevulinic acid—Dermatitis—Conjugated Estrogens—prostate cancer	0.000397	0.000597	CcSEcCtD
Aminolevulinic acid—ALAD—Metabolism—NCOA3—prostate cancer	0.000397	0.00456	CbGpPWpGaD
Aminolevulinic acid—Haemoglobin—Prednisone—prostate cancer	0.000396	0.000596	CcSEcCtD
Aminolevulinic acid—Headache—Conjugated Estrogens—prostate cancer	0.000395	0.000593	CcSEcCtD
Aminolevulinic acid—Haemorrhage—Prednisone—prostate cancer	0.000394	0.000593	CcSEcCtD
Aminolevulinic acid—Alanine aminotransferase increased—Epirubicin—prostate cancer	0.000393	0.000591	CcSEcCtD
Aminolevulinic acid—Infection—Etoposide—prostate cancer	0.000388	0.000584	CcSEcCtD
Aminolevulinic acid—Mental disorder—Capecitabine—prostate cancer	0.000388	0.000583	CcSEcCtD
Aminolevulinic acid—Erythema—Capecitabine—prostate cancer	0.000385	0.000579	CcSEcCtD
Aminolevulinic acid—SLC15A2—SLC-mediated transmembrane transport—SLC22A1—prostate cancer	0.000384	0.00442	CbGpPWpGaD
Aminolevulinic acid—Thrombocytopenia—Etoposide—prostate cancer	0.000383	0.000575	CcSEcCtD
Aminolevulinic acid—Skin disorder—Etoposide—prostate cancer	0.00038	0.000571	CcSEcCtD
Aminolevulinic acid—ALAD—Metabolism—HPGDS—prostate cancer	0.000379	0.00435	CbGpPWpGaD
Aminolevulinic acid—Dry skin—Doxorubicin—prostate cancer	0.000378	0.000568	CcSEcCtD
Aminolevulinic acid—Nausea—Goserelin—prostate cancer	0.000378	0.000568	CcSEcCtD
Aminolevulinic acid—ALAD—Metabolism—CYP2C19—prostate cancer	0.000376	0.00433	CbGpPWpGaD
Aminolevulinic acid—Nausea—Conjugated Estrogens—prostate cancer	0.000374	0.000563	CcSEcCtD
Aminolevulinic acid—Urticaria—Mitoxantrone—prostate cancer	0.000373	0.000561	CcSEcCtD
Aminolevulinic acid—SLC15A2—Transmembrane transport of small molecules—SLC39A1—prostate cancer	0.000372	0.00428	CbGpPWpGaD
Aminolevulinic acid—Body temperature increased—Mitoxantrone—prostate cancer	0.000371	0.000558	CcSEcCtD
Aminolevulinic acid—Aspartate aminotransferase increased—Doxorubicin—prostate cancer	0.000371	0.000558	CcSEcCtD
Aminolevulinic acid—Eye disorder—Prednisone—prostate cancer	0.000368	0.000554	CcSEcCtD
Aminolevulinic acid—Anaemia—Docetaxel—prostate cancer	0.000368	0.000553	CcSEcCtD
Aminolevulinic acid—ALAD—Metabolism—GSTT1—prostate cancer	0.000367	0.00422	CbGpPWpGaD
Aminolevulinic acid—ALAD—Metabolism—ACHE—prostate cancer	0.000367	0.00422	CbGpPWpGaD
Aminolevulinic acid—Hypotension—Etoposide—prostate cancer	0.000365	0.000549	CcSEcCtD
Aminolevulinic acid—Alanine aminotransferase increased—Doxorubicin—prostate cancer	0.000364	0.000547	CcSEcCtD
Aminolevulinic acid—ALAD—Metabolism—CYP2A6—prostate cancer	0.000363	0.00417	CbGpPWpGaD
Aminolevulinic acid—Angiopathy—Prednisone—prostate cancer	0.000358	0.000538	CcSEcCtD
Aminolevulinic acid—Pruritus—Estradiol—prostate cancer	0.000357	0.000536	CcSEcCtD
Aminolevulinic acid—SLC15A1—SLC-mediated transmembrane transport—SLC22A1—prostate cancer	0.000357	0.0041	CbGpPWpGaD
Aminolevulinic acid—Anaemia—Capecitabine—prostate cancer	0.000356	0.000535	CcSEcCtD
Aminolevulinic acid—ALAD—Metabolism—AKR1C3—prostate cancer	0.000353	0.00406	CbGpPWpGaD
Aminolevulinic acid—Photosensitivity reaction—Epirubicin—prostate cancer	0.000352	0.000529	CcSEcCtD
Aminolevulinic acid—ALAD—Metabolism—PRKACB—prostate cancer	0.000351	0.00404	CbGpPWpGaD
Aminolevulinic acid—Paraesthesia—Etoposide—prostate cancer	0.000351	0.000528	CcSEcCtD
Aminolevulinic acid—ALAD—Metabolism—CYP17A1—prostate cancer	0.000348	0.004	CbGpPWpGaD
Aminolevulinic acid—Mental disorder—Prednisone—prostate cancer	0.000345	0.000519	CcSEcCtD
Aminolevulinic acid—SLC15A1—Transmembrane transport of small molecules—SLC39A1—prostate cancer	0.000345	0.00397	CbGpPWpGaD
Aminolevulinic acid—Diarrhoea—Estradiol—prostate cancer	0.000345	0.000519	CcSEcCtD
Aminolevulinic acid—Convulsion—Docetaxel—prostate cancer	0.000345	0.000518	CcSEcCtD
Aminolevulinic acid—Infestation—Epirubicin—prostate cancer	0.000344	0.000516	CcSEcCtD
Aminolevulinic acid—Infestation NOS—Epirubicin—prostate cancer	0.000344	0.000516	CcSEcCtD
Aminolevulinic acid—Erythema—Prednisone—prostate cancer	0.000343	0.000516	CcSEcCtD
Aminolevulinic acid—Gastrointestinal disorder—Etoposide—prostate cancer	0.000337	0.000507	CcSEcCtD
Aminolevulinic acid—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—prostate cancer	0.000336	0.000506	CcSEcCtD
Aminolevulinic acid—Pain—Etoposide—prostate cancer	0.000334	0.000502	CcSEcCtD
Aminolevulinic acid—ALAD—Metabolism—NCOA2—prostate cancer	0.000331	0.00381	CbGpPWpGaD
Aminolevulinic acid—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—prostate cancer	0.000326	0.00049	CcSEcCtD
Aminolevulinic acid—Photosensitivity reaction—Doxorubicin—prostate cancer	0.000325	0.000489	CcSEcCtD
Aminolevulinic acid—Hepatobiliary disease—Epirubicin—prostate cancer	0.000325	0.000488	CcSEcCtD
Aminolevulinic acid—Oedema—Docetaxel—prostate cancer	0.000325	0.000488	CcSEcCtD
Aminolevulinic acid—Discomfort—Capecitabine—prostate cancer	0.000324	0.000487	CcSEcCtD
Aminolevulinic acid—Infection—Docetaxel—prostate cancer	0.000323	0.000485	CcSEcCtD
Aminolevulinic acid—Diarrhoea—Mitoxantrone—prostate cancer	0.000321	0.000483	CcSEcCtD
Aminolevulinic acid—Vomiting—Estradiol—prostate cancer	0.000321	0.000482	CcSEcCtD
Aminolevulinic acid—Nervous system disorder—Docetaxel—prostate cancer	0.000319	0.000479	CcSEcCtD
Aminolevulinic acid—Thrombocytopenia—Docetaxel—prostate cancer	0.000318	0.000478	CcSEcCtD
Aminolevulinic acid—Rash—Estradiol—prostate cancer	0.000318	0.000478	CcSEcCtD
Aminolevulinic acid—Infestation NOS—Doxorubicin—prostate cancer	0.000318	0.000478	CcSEcCtD
Aminolevulinic acid—Infestation—Doxorubicin—prostate cancer	0.000318	0.000478	CcSEcCtD
Aminolevulinic acid—Dermatitis—Estradiol—prostate cancer	0.000318	0.000478	CcSEcCtD
Aminolevulinic acid—Anaemia—Prednisone—prostate cancer	0.000317	0.000477	CcSEcCtD
Aminolevulinic acid—ALAD—Metabolism—SLC5A5—prostate cancer	0.000316	0.00363	CbGpPWpGaD
Aminolevulinic acid—Headache—Estradiol—prostate cancer	0.000316	0.000475	CcSEcCtD
Aminolevulinic acid—Skin disorder—Docetaxel—prostate cancer	0.000315	0.000474	CcSEcCtD
Aminolevulinic acid—Oedema—Capecitabine—prostate cancer	0.000314	0.000473	CcSEcCtD
Aminolevulinic acid—Infection—Capecitabine—prostate cancer	0.000312	0.00047	CcSEcCtD
Aminolevulinic acid—Urticaria—Etoposide—prostate cancer	0.00031	0.000467	CcSEcCtD
Aminolevulinic acid—Haemoglobin—Epirubicin—prostate cancer	0.00031	0.000466	CcSEcCtD
Aminolevulinic acid—Body temperature increased—Etoposide—prostate cancer	0.000309	0.000464	CcSEcCtD
Aminolevulinic acid—ALAD—Metabolism—CYP2E1—prostate cancer	0.000309	0.00355	CbGpPWpGaD
Aminolevulinic acid—Nervous system disorder—Capecitabine—prostate cancer	0.000308	0.000464	CcSEcCtD
Aminolevulinic acid—Haemorrhage—Epirubicin—prostate cancer	0.000308	0.000464	CcSEcCtD
Aminolevulinic acid—Thrombocytopenia—Capecitabine—prostate cancer	0.000308	0.000463	CcSEcCtD
Aminolevulinic acid—Hypoaesthesia—Epirubicin—prostate cancer	0.000307	0.000461	CcSEcCtD
Aminolevulinic acid—Skin disorder—Capecitabine—prostate cancer	0.000305	0.000459	CcSEcCtD
Aminolevulinic acid—ALAD—Metabolism—NQO1—prostate cancer	0.000305	0.00351	CbGpPWpGaD
Aminolevulinic acid—Hypotension—Docetaxel—prostate cancer	0.000304	0.000456	CcSEcCtD
Aminolevulinic acid—SLC15A2—Transmembrane transport of small molecules—CYP7B1—prostate cancer	0.000303	0.00349	CbGpPWpGaD
Aminolevulinic acid—ALAD—Metabolism—TH—prostate cancer	0.000301	0.00346	CbGpPWpGaD
Aminolevulinic acid—Hepatobiliary disease—Doxorubicin—prostate cancer	0.000301	0.000452	CcSEcCtD
Aminolevulinic acid—Nausea—Estradiol—prostate cancer	0.0003	0.00045	CcSEcCtD
Aminolevulinic acid—Vomiting—Mitoxantrone—prostate cancer	0.000299	0.000449	CcSEcCtD
Aminolevulinic acid—ALAD—Metabolism—CYP3A4—prostate cancer	0.000298	0.00342	CbGpPWpGaD
Aminolevulinic acid—Convulsion—Prednisone—prostate cancer	0.000297	0.000447	CcSEcCtD
Aminolevulinic acid—Rash—Mitoxantrone—prostate cancer	0.000296	0.000445	CcSEcCtD
Aminolevulinic acid—Dermatitis—Mitoxantrone—prostate cancer	0.000296	0.000445	CcSEcCtD
Aminolevulinic acid—SLC15A2—Transmembrane transport of small molecules—SLC12A2—prostate cancer	0.000295	0.0034	CbGpPWpGaD
Aminolevulinic acid—SLC15A2—Transmembrane transport of small molecules—SLC26A4—prostate cancer	0.000295	0.0034	CbGpPWpGaD
Aminolevulinic acid—Headache—Mitoxantrone—prostate cancer	0.000294	0.000443	CcSEcCtD
Aminolevulinic acid—Hypotension—Capecitabine—prostate cancer	0.000294	0.000442	CcSEcCtD
Aminolevulinic acid—ALAD—Metabolism—CYP1B1—prostate cancer	0.000293	0.00336	CbGpPWpGaD
Aminolevulinic acid—Paraesthesia—Docetaxel—prostate cancer	0.000292	0.000438	CcSEcCtD
Aminolevulinic acid—Unspecified disorder of skin and subcutaneous tissue—Prednisone—prostate cancer	0.00029	0.000436	CcSEcCtD
Aminolevulinic acid—Discomfort—Prednisone—prostate cancer	0.000289	0.000434	CcSEcCtD
Aminolevulinic acid—Eye disorder—Epirubicin—prostate cancer	0.000288	0.000433	CcSEcCtD
Aminolevulinic acid—Haemoglobin—Doxorubicin—prostate cancer	0.000287	0.000431	CcSEcCtD
Aminolevulinic acid—Cardiac disorder—Epirubicin—prostate cancer	0.000286	0.00043	CcSEcCtD
Aminolevulinic acid—Haemorrhage—Doxorubicin—prostate cancer	0.000285	0.000429	CcSEcCtD
Aminolevulinic acid—Hypoaesthesia—Doxorubicin—prostate cancer	0.000284	0.000427	CcSEcCtD
Aminolevulinic acid—ALAD—Metabolism—GGT1—prostate cancer	0.000283	0.00326	CbGpPWpGaD
Aminolevulinic acid—Paraesthesia—Capecitabine—prostate cancer	0.000282	0.000425	CcSEcCtD
Aminolevulinic acid—SLC15A1—Transmembrane transport of small molecules—CYP7B1—prostate cancer	0.000281	0.00324	CbGpPWpGaD
Aminolevulinic acid—SLC15A2—SLC-mediated transmembrane transport—SLC5A5—prostate cancer	0.00028	0.00323	CbGpPWpGaD
Aminolevulinic acid—Gastrointestinal disorder—Docetaxel—prostate cancer	0.00028	0.000422	CcSEcCtD
Aminolevulinic acid—Oedema—Prednisone—prostate cancer	0.00028	0.000421	CcSEcCtD
Aminolevulinic acid—Angiopathy—Epirubicin—prostate cancer	0.00028	0.000421	CcSEcCtD
Aminolevulinic acid—Nausea—Mitoxantrone—prostate cancer	0.000279	0.00042	CcSEcCtD
Aminolevulinic acid—ALAD—Metabolism—NCOA1—prostate cancer	0.000279	0.00321	CbGpPWpGaD
Aminolevulinic acid—Infection—Prednisone—prostate cancer	0.000278	0.000418	CcSEcCtD
Aminolevulinic acid—Pain—Docetaxel—prostate cancer	0.000278	0.000418	CcSEcCtD
Aminolevulinic acid—Chills—Epirubicin—prostate cancer	0.000277	0.000416	CcSEcCtD
Aminolevulinic acid—Pruritus—Etoposide—prostate cancer	0.000277	0.000416	CcSEcCtD
Aminolevulinic acid—ALAD—Metabolism—CYP19A1—prostate cancer	0.000275	0.00316	CbGpPWpGaD
Aminolevulinic acid—Nervous system disorder—Prednisone—prostate cancer	0.000275	0.000413	CcSEcCtD
Aminolevulinic acid—SLC15A1—Transmembrane transport of small molecules—SLC12A2—prostate cancer	0.000274	0.00315	CbGpPWpGaD
Aminolevulinic acid—SLC15A1—Transmembrane transport of small molecules—SLC26A4—prostate cancer	0.000274	0.00315	CbGpPWpGaD
Aminolevulinic acid—Skin disorder—Prednisone—prostate cancer	0.000272	0.000409	CcSEcCtD
Aminolevulinic acid—Gastrointestinal disorder—Capecitabine—prostate cancer	0.000271	0.000408	CcSEcCtD
Aminolevulinic acid—Mental disorder—Epirubicin—prostate cancer	0.00027	0.000406	CcSEcCtD
Aminolevulinic acid—Pain—Capecitabine—prostate cancer	0.000269	0.000404	CcSEcCtD
Aminolevulinic acid—Erythema—Epirubicin—prostate cancer	0.000268	0.000404	CcSEcCtD
Aminolevulinic acid—Diarrhoea—Etoposide—prostate cancer	0.000267	0.000402	CcSEcCtD
Aminolevulinic acid—Eye disorder—Doxorubicin—prostate cancer	0.000267	0.000401	CcSEcCtD
Aminolevulinic acid—ALAD—Metabolism—RXRA—prostate cancer	0.000265	0.00305	CbGpPWpGaD
Aminolevulinic acid—Cardiac disorder—Doxorubicin—prostate cancer	0.000265	0.000398	CcSEcCtD
Aminolevulinic acid—Tension—Epirubicin—prostate cancer	0.000263	0.000396	CcSEcCtD
Aminolevulinic acid—Nervousness—Epirubicin—prostate cancer	0.000261	0.000392	CcSEcCtD
Aminolevulinic acid—SLC15A1—SLC-mediated transmembrane transport—SLC5A5—prostate cancer	0.00026	0.00299	CbGpPWpGaD
Aminolevulinic acid—Angiopathy—Doxorubicin—prostate cancer	0.000259	0.000389	CcSEcCtD
Aminolevulinic acid—Body temperature increased—Docetaxel—prostate cancer	0.000257	0.000386	CcSEcCtD
Aminolevulinic acid—Chills—Doxorubicin—prostate cancer	0.000256	0.000385	CcSEcCtD
Aminolevulinic acid—ALAD—Metabolism—COMT—prostate cancer	0.000256	0.00294	CbGpPWpGaD
Aminolevulinic acid—ALAD—Metabolism—GSTP1—prostate cancer	0.000254	0.00293	CbGpPWpGaD
Aminolevulinic acid—Paraesthesia—Prednisone—prostate cancer	0.000252	0.000378	CcSEcCtD
Aminolevulinic acid—ALAD—Metabolism—ITPR1—prostate cancer	0.00025	0.00288	CbGpPWpGaD
Aminolevulinic acid—Mental disorder—Doxorubicin—prostate cancer	0.00025	0.000376	CcSEcCtD
Aminolevulinic acid—Urticaria—Capecitabine—prostate cancer	0.00025	0.000376	CcSEcCtD
Aminolevulinic acid—Body temperature increased—Capecitabine—prostate cancer	0.000249	0.000374	CcSEcCtD
Aminolevulinic acid—Vomiting—Etoposide—prostate cancer	0.000248	0.000374	CcSEcCtD
Aminolevulinic acid—Erythema—Doxorubicin—prostate cancer	0.000248	0.000373	CcSEcCtD
Aminolevulinic acid—Anaemia—Epirubicin—prostate cancer	0.000248	0.000373	CcSEcCtD
Aminolevulinic acid—Rash—Etoposide—prostate cancer	0.000246	0.00037	CcSEcCtD
Aminolevulinic acid—Dermatitis—Etoposide—prostate cancer	0.000246	0.00037	CcSEcCtD
Aminolevulinic acid—Headache—Etoposide—prostate cancer	0.000245	0.000368	CcSEcCtD
Aminolevulinic acid—Tension—Doxorubicin—prostate cancer	0.000244	0.000366	CcSEcCtD
Aminolevulinic acid—Nervousness—Doxorubicin—prostate cancer	0.000241	0.000363	CcSEcCtD
Aminolevulinic acid—SLC15A2—Transmembrane transport of small molecules—SLC22A3—prostate cancer	0.00024	0.00276	CbGpPWpGaD
Aminolevulinic acid—ALAD—Metabolism—TYMS—prostate cancer	0.000237	0.00272	CbGpPWpGaD
Aminolevulinic acid—ALAD—Metabolism—GSTM1—prostate cancer	0.000234	0.00269	CbGpPWpGaD
Aminolevulinic acid—Convulsion—Epirubicin—prostate cancer	0.000233	0.00035	CcSEcCtD
Aminolevulinic acid—Nausea—Etoposide—prostate cancer	0.000232	0.000349	CcSEcCtD
Aminolevulinic acid—Pruritus—Docetaxel—prostate cancer	0.00023	0.000345	CcSEcCtD
Aminolevulinic acid—Anaemia—Doxorubicin—prostate cancer	0.00023	0.000345	CcSEcCtD
Aminolevulinic acid—ALAD—Metabolism—LPL—prostate cancer	0.00023	0.00264	CbGpPWpGaD
Aminolevulinic acid—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—prostate cancer	0.000227	0.000341	CcSEcCtD
Aminolevulinic acid—Discomfort—Epirubicin—prostate cancer	0.000226	0.000339	CcSEcCtD
Aminolevulinic acid—Urticaria—Prednisone—prostate cancer	0.000223	0.000335	CcSEcCtD
Aminolevulinic acid—Pruritus—Capecitabine—prostate cancer	0.000222	0.000334	CcSEcCtD
Aminolevulinic acid—SLC15A1—Transmembrane transport of small molecules—SLC22A3—prostate cancer	0.000222	0.00256	CbGpPWpGaD
Aminolevulinic acid—Diarrhoea—Docetaxel—prostate cancer	0.000222	0.000334	CcSEcCtD
Aminolevulinic acid—ALAD—Metabolism—CYP1A1—prostate cancer	0.000222	0.00255	CbGpPWpGaD
Aminolevulinic acid—Body temperature increased—Prednisone—prostate cancer	0.000221	0.000333	CcSEcCtD
Aminolevulinic acid—SLC15A2—Transmembrane transport of small molecules—ABCG5—prostate cancer	0.000221	0.00254	CbGpPWpGaD
Aminolevulinic acid—ALAD—Metabolism—ERCC2—prostate cancer	0.00022	0.00253	CbGpPWpGaD
Aminolevulinic acid—Oedema—Epirubicin—prostate cancer	0.000219	0.000329	CcSEcCtD
Aminolevulinic acid—Infection—Epirubicin—prostate cancer	0.000218	0.000327	CcSEcCtD
Aminolevulinic acid—Convulsion—Doxorubicin—prostate cancer	0.000215	0.000324	CcSEcCtD
Aminolevulinic acid—Diarrhoea—Capecitabine—prostate cancer	0.000215	0.000323	CcSEcCtD
Aminolevulinic acid—Nervous system disorder—Epirubicin—prostate cancer	0.000215	0.000323	CcSEcCtD
Aminolevulinic acid—Thrombocytopenia—Epirubicin—prostate cancer	0.000215	0.000322	CcSEcCtD
Aminolevulinic acid—Skin disorder—Epirubicin—prostate cancer	0.000213	0.00032	CcSEcCtD
Aminolevulinic acid—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—prostate cancer	0.00021	0.000316	CcSEcCtD
Aminolevulinic acid—Discomfort—Doxorubicin—prostate cancer	0.000209	0.000314	CcSEcCtD
Aminolevulinic acid—ALAD—Metabolism—MTHFR—prostate cancer	0.000207	0.00238	CbGpPWpGaD
Aminolevulinic acid—Vomiting—Docetaxel—prostate cancer	0.000207	0.00031	CcSEcCtD
Aminolevulinic acid—SLC15A1—Transmembrane transport of small molecules—ABCG5—prostate cancer	0.000205	0.00236	CbGpPWpGaD
Aminolevulinic acid—Rash—Docetaxel—prostate cancer	0.000205	0.000308	CcSEcCtD
Aminolevulinic acid—Hypotension—Epirubicin—prostate cancer	0.000205	0.000308	CcSEcCtD
Aminolevulinic acid—Dermatitis—Docetaxel—prostate cancer	0.000205	0.000308	CcSEcCtD
Aminolevulinic acid—Headache—Docetaxel—prostate cancer	0.000203	0.000306	CcSEcCtD
Aminolevulinic acid—ALAD—Metabolism—PPARA—prostate cancer	0.000203	0.00233	CbGpPWpGaD
Aminolevulinic acid—Oedema—Doxorubicin—prostate cancer	0.000203	0.000305	CcSEcCtD
Aminolevulinic acid—Infection—Doxorubicin—prostate cancer	0.000201	0.000303	CcSEcCtD
Aminolevulinic acid—Vomiting—Capecitabine—prostate cancer	0.0002	0.000301	CcSEcCtD
Aminolevulinic acid—Nervous system disorder—Doxorubicin—prostate cancer	0.000199	0.000299	CcSEcCtD
Aminolevulinic acid—Thrombocytopenia—Doxorubicin—prostate cancer	0.000198	0.000298	CcSEcCtD
Aminolevulinic acid—Rash—Capecitabine—prostate cancer	0.000198	0.000298	CcSEcCtD
Aminolevulinic acid—Pruritus—Prednisone—prostate cancer	0.000198	0.000298	CcSEcCtD
Aminolevulinic acid—Dermatitis—Capecitabine—prostate cancer	0.000198	0.000298	CcSEcCtD
Aminolevulinic acid—Headache—Capecitabine—prostate cancer	0.000197	0.000296	CcSEcCtD
Aminolevulinic acid—Skin disorder—Doxorubicin—prostate cancer	0.000197	0.000296	CcSEcCtD
Aminolevulinic acid—Paraesthesia—Epirubicin—prostate cancer	0.000197	0.000296	CcSEcCtD
Aminolevulinic acid—SLC15A2—Transmembrane transport of small molecules—SLC22A1—prostate cancer	0.000195	0.00225	CbGpPWpGaD
Aminolevulinic acid—Nausea—Docetaxel—prostate cancer	0.000193	0.00029	CcSEcCtD
Aminolevulinic acid—Diarrhoea—Prednisone—prostate cancer	0.000192	0.000288	CcSEcCtD
Aminolevulinic acid—ALAD—Metabolism—CAV1—prostate cancer	0.000191	0.00219	CbGpPWpGaD
Aminolevulinic acid—Hypotension—Doxorubicin—prostate cancer	0.000189	0.000285	CcSEcCtD
Aminolevulinic acid—Gastrointestinal disorder—Epirubicin—prostate cancer	0.000189	0.000284	CcSEcCtD
Aminolevulinic acid—Pain—Epirubicin—prostate cancer	0.000187	0.000282	CcSEcCtD
Aminolevulinic acid—Nausea—Capecitabine—prostate cancer	0.000187	0.000281	CcSEcCtD
Aminolevulinic acid—SLC15A2—Transmembrane transport of small molecules—GNG5—prostate cancer	0.000186	0.00214	CbGpPWpGaD
Aminolevulinic acid—Paraesthesia—Doxorubicin—prostate cancer	0.000182	0.000274	CcSEcCtD
Aminolevulinic acid—SLC15A1—Transmembrane transport of small molecules—SLC22A1—prostate cancer	0.000181	0.00209	CbGpPWpGaD
Aminolevulinic acid—Vomiting—Prednisone—prostate cancer	0.000178	0.000268	CcSEcCtD
Aminolevulinic acid—Rash—Prednisone—prostate cancer	0.000177	0.000266	CcSEcCtD
Aminolevulinic acid—Dermatitis—Prednisone—prostate cancer	0.000176	0.000265	CcSEcCtD
Aminolevulinic acid—Headache—Prednisone—prostate cancer	0.000175	0.000264	CcSEcCtD
Aminolevulinic acid—Gastrointestinal disorder—Doxorubicin—prostate cancer	0.000175	0.000263	CcSEcCtD
Aminolevulinic acid—Urticaria—Epirubicin—prostate cancer	0.000174	0.000262	CcSEcCtD
Aminolevulinic acid—ALAD—Metabolism—PIK3CG—prostate cancer	0.000174	0.002	CbGpPWpGaD
Aminolevulinic acid—Pain—Doxorubicin—prostate cancer	0.000173	0.000261	CcSEcCtD
Aminolevulinic acid—Body temperature increased—Epirubicin—prostate cancer	0.000173	0.00026	CcSEcCtD
Aminolevulinic acid—SLC15A1—Transmembrane transport of small molecules—GNG5—prostate cancer	0.000172	0.00198	CbGpPWpGaD
Aminolevulinic acid—Nausea—Prednisone—prostate cancer	0.000166	0.00025	CcSEcCtD
Aminolevulinic acid—ALAD—Metabolism—INS—prostate cancer	0.000164	0.00189	CbGpPWpGaD
Aminolevulinic acid—Urticaria—Doxorubicin—prostate cancer	0.000161	0.000242	CcSEcCtD
Aminolevulinic acid—ALAD—Metabolism—CREBBP—prostate cancer	0.000161	0.00185	CbGpPWpGaD
Aminolevulinic acid—Body temperature increased—Doxorubicin—prostate cancer	0.00016	0.000241	CcSEcCtD
Aminolevulinic acid—SLC15A2—Transmembrane transport of small molecules—PRKACB—prostate cancer	0.000158	0.00182	CbGpPWpGaD
Aminolevulinic acid—Pruritus—Epirubicin—prostate cancer	0.000155	0.000233	CcSEcCtD
Aminolevulinic acid—ALAD—Metabolism—PIK3CD—prostate cancer	0.000153	0.00176	CbGpPWpGaD
Aminolevulinic acid—Diarrhoea—Epirubicin—prostate cancer	0.00015	0.000225	CcSEcCtD
Aminolevulinic acid—SLC15A2—Transmembrane transport of small molecules—NCOA2—prostate cancer	0.000149	0.00172	CbGpPWpGaD
Aminolevulinic acid—SLC15A1—Transmembrane transport of small molecules—PRKACB—prostate cancer	0.000147	0.00169	CbGpPWpGaD
Aminolevulinic acid—ALAD—Metabolism—NOS3—prostate cancer	0.000144	0.00166	CbGpPWpGaD
Aminolevulinic acid—Pruritus—Doxorubicin—prostate cancer	0.000143	0.000216	CcSEcCtD
Aminolevulinic acid—SLC15A2—Transmembrane transport of small molecules—SLC5A5—prostate cancer	0.000143	0.00164	CbGpPWpGaD
Aminolevulinic acid—Vomiting—Epirubicin—prostate cancer	0.000139	0.000209	CcSEcCtD
Aminolevulinic acid—Diarrhoea—Doxorubicin—prostate cancer	0.000139	0.000209	CcSEcCtD
Aminolevulinic acid—SLC15A1—Transmembrane transport of small molecules—NCOA2—prostate cancer	0.000139	0.00159	CbGpPWpGaD
Aminolevulinic acid—Rash—Epirubicin—prostate cancer	0.000138	0.000208	CcSEcCtD
Aminolevulinic acid—Dermatitis—Epirubicin—prostate cancer	0.000138	0.000207	CcSEcCtD
Aminolevulinic acid—Headache—Epirubicin—prostate cancer	0.000137	0.000206	CcSEcCtD
Aminolevulinic acid—ALAD—Metabolism—PIK3CB—prostate cancer	0.000133	0.00153	CbGpPWpGaD
Aminolevulinic acid—SLC15A1—Transmembrane transport of small molecules—SLC5A5—prostate cancer	0.000132	0.00152	CbGpPWpGaD
Aminolevulinic acid—ALAD—Metabolism—PTGS2—prostate cancer	0.000132	0.00152	CbGpPWpGaD
Aminolevulinic acid—Nausea—Epirubicin—prostate cancer	0.00013	0.000196	CcSEcCtD
Aminolevulinic acid—Vomiting—Doxorubicin—prostate cancer	0.000129	0.000194	CcSEcCtD
Aminolevulinic acid—Rash—Doxorubicin—prostate cancer	0.000128	0.000192	CcSEcCtD
Aminolevulinic acid—Dermatitis—Doxorubicin—prostate cancer	0.000128	0.000192	CcSEcCtD
Aminolevulinic acid—Headache—Doxorubicin—prostate cancer	0.000127	0.000191	CcSEcCtD
Aminolevulinic acid—SLC15A2—Transmembrane transport of small molecules—NCOA1—prostate cancer	0.000126	0.00145	CbGpPWpGaD
Aminolevulinic acid—Nausea—Doxorubicin—prostate cancer	0.00012	0.000181	CcSEcCtD
Aminolevulinic acid—SLC15A2—Transmembrane transport of small molecules—RXRA—prostate cancer	0.00012	0.00138	CbGpPWpGaD
Aminolevulinic acid—SLC15A1—Transmembrane transport of small molecules—NCOA1—prostate cancer	0.000117	0.00134	CbGpPWpGaD
Aminolevulinic acid—ALAD—Metabolism—PTEN—prostate cancer	0.000115	0.00132	CbGpPWpGaD
Aminolevulinic acid—SLC15A1—Transmembrane transport of small molecules—RXRA—prostate cancer	0.000111	0.00128	CbGpPWpGaD
Aminolevulinic acid—ALAD—Metabolism—EP300—prostate cancer	0.00011	0.00126	CbGpPWpGaD
Aminolevulinic acid—SLC15A2—Transmembrane transport of small molecules—PPARA—prostate cancer	9.15e-05	0.00105	CbGpPWpGaD
Aminolevulinic acid—SLC15A1—Transmembrane transport of small molecules—PPARA—prostate cancer	8.49e-05	0.000976	CbGpPWpGaD
Aminolevulinic acid—ALAD—Metabolism—PIK3CA—prostate cancer	8.11e-05	0.000933	CbGpPWpGaD
Aminolevulinic acid—SLC15A2—Transmembrane transport of small molecules—CREBBP—prostate cancer	7.26e-05	0.000835	CbGpPWpGaD
Aminolevulinic acid—SLC15A1—Transmembrane transport of small molecules—CREBBP—prostate cancer	6.74e-05	0.000775	CbGpPWpGaD
Aminolevulinic acid—ALAD—Metabolism—AKT1—prostate cancer	6.63e-05	0.000762	CbGpPWpGaD
